Colin S Goodchild

Title: Colin S Goodchild: Innovator in Neuroactive Steroids

Introduction

Colin S Goodchild is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of neuroprotection through his innovative research and patents. His work focuses on the use of neuroactive steroids to address inflammation in the central nervous system.

Latest Patents

Colin S Goodchild holds a patent titled "Neuroactive steroids and their use to facilitate neuroprotection." This patent outlines methods for treating inflammation or ameliorating neuroinflammatory-promoting conditions in the central nervous system. The invention emphasizes the use of non-hormonal neuroactive steroids formulated in a sulfobutyl ether beta-cyclodextrin composition. The steroids mentioned in the patent include alphaxalone, alphadolone, allopregnanolone, pregnanolone, ganaxolone, hydroxydione, minaxolone, Org20599, Org21465, CT1341, and compounds of Formula (I). The patent also details the types of neuroinflammatory-promoting conditions, the specific cyclodextrin used, and the molar ratio of neuroactive steroid to cyclodextrin.

Career Highlights

Colin S Goodchild is associated with Goodchild Investments Pty Ltd, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating neuroinflammatory conditions, showcasing his commitment to improving health outcomes.

Collaborations

Colin collaborates with Juliet M Goodchild, contributing to the innovative environment at Goodchild Investments Pty Ltd. Their partnership enhances the research capabilities and fosters a collaborative approach to tackling complex health issues.

Conclusion

Colin S Goodchild is a pioneering inventor whose work in neuroactive steroids has the potential to revolutionize treatments for neuroinflammatory conditions. His contributions to the field of neuroprotection are significant and reflect his dedication to advancing medical science.